The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early-stage ...

Mitochondria have long been known as the tiny organelles that act as the battery packs inside our cells while also serving as ...

The test identifies patients for targeted therapies in breast, colorectal ... may benefit from treatment with targeted therapies. MI Cancer Seek™ has received approval from the Food and Drug ...

Many patients with dense breast tissue currently have to pay out of pocket or forgo potentially life-saving additional ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...

The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with ...

announced the U.S. Food and Drug Administration's ("FDA") Medical Device Advisory Committee Panel's (the "Advisory Panel") favorable recommendation with 9 panelists voting in favor and 5 voting ...

Collaborative research at the University of Ottawa sheds new light on the mysteries of mitochondrial dynamics and its likely ...